 Mustang Bio, Inc. Mustang MBIO, a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that it will host the Companys 2020 Annual Meeting of Stockholders Annual Meeting virtually due to public health concerns resulting from the coronavirus COVID-19 outbreak, and government-recommended and required limits on public gatherings. Holding the Annual Meeting online will also protect the health and safety of the Companys stockholders, directors and employees. The Annual Meeting will begin at 3:00 p.m. Eastern Time on Wednesday, June 17, 2020, and will be conducted in a virtual format only. 